Skin Cancer Research at City of Hope
Getting treated for skin cancer at City of Hope means you are steps away from labs where new treatments for cancer are being developed every day. That proximity means you benefit from something unique in cancer care — bench to bedside treatment. “Bench to bedside” means innovative research we are conducting in our labs is moved quickly to the bedside to treat our patients.
Cancers are able to survive and thrive because of genetic abnormalities that keep them from being detected and destroyed by the body’s immune system. Research is revealing the specific mutations (problems within the DNA in a cell) causing these abnormalities and using that information to tailor therapies to specific patients’ tumor cells.
For example, with melanoma, recent advances have revealed specific genetic pathways that drive melanoma development. Our genetics team is on the forefront of new discoveries about why people develop melanoma — and precision medicine techniques allow them to target those problems within cells, and disrupt the process that leads to cancer.
Clinical trials at City of Hope
Melanoma is a disease that can act many different ways in the body. Research at City of Hope — driven by patient-specific, individualized treatment strategies — is focused on those differences, and on designing therapies that affect how melanoma develops, progresses and spreads. Click here to learn more about clinical research at City of Hope.